|

The iBlad App - a National, Exploratory Study on a Multimodality Smartphone App for Bladder Cancer Patients

RECRUITINGSponsored by Odense University Hospital
Actively Recruiting
SponsorOdense University Hospital
Started2022-12-12
Est. completion2024-06-30
Eligibility
Age18 Years – 100 Years
Healthy vol.Accepted
View on ClinicalTrials.gov →

NCT05710159

Summary

The aims of this project are: * to develop and implement a national multimodality application for patients with bladder cancer that builds upon knowledge from the iBLAD study. * to investigate how the app, containing PRO questions on symptoms and QoL, information for health care providers, and peer-to-peer advice, can provide more knowledge on symptoms, QoL, and the need for supportive care. * to examine the usability of and patient satisfaction with the app using qualitative methods.

Eligibility

Age: 18 Years – 100 YearsHealthy volunteers accepted
Inclusion Criteria:

* Patients with bladder cancer defined as both urothelial tract-, bladder- and urethral cancer initiating first or second-line standard therapy with either chemotherapy or immunotherapy
* Age ≥ 18 years,
* Performance status ≤ 2
* Ability to read Danish
* No serious cognitive impairment
* Informed consent.

Exclusion Criteria:

* No smartphone,
* Dementia, mental alteration, or psychiatric disease that can compromise informed consent from the patient and/or adherence to the protocol and the monitoring of the trial.

Conditions2

Bladder CancerCancer

Browse More Trials

Cancer trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.